Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 5/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23010396 | 1.00 | DGAT1 (0.35) | DGAT1MEN1KMT2ACNR2NPSR1 | |
| SCHEMBL13655643 | 0.81 | DGAT1 (0.34) | DGAT1CNR2NPSR1 | |
| Hydrochloric Acid SCHEMBL7330618 | 0.79 | DPP4 (0.35) | DGAT1CNR2NPSR1 | |
| SCHEMBL8222052 | 0.76 | POLB (0.46) | MEN1KMT2ATP53 | |
| SCHEMBL23084588 | 0.76 | POLB (0.46) | MEN1KMT2ATP53 | |
| SCHEMBL8229637 | 0.76 | POLB (0.46) | MEN1KMT2ATP53 | |
| SCHEMBL21427835 | 0.73 | DGAT1 (0.38) | DGAT1CNR2NPSR1 | |
| SCHEMBL12563721 | 0.72 | ELANE (0.43) | DGAT1MEN1KMT2ACNR2NPSR1 | |
| SCHEMBL6840349 | 0.70 | DGAT1 (0.39) | DGAT1 | |
| SCHEMBL18312018 | 0.70 | DGAT1 (0.39) | DGAT1CNR2NPSR1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210017154-A1 | N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017154-A1 | N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | COG5, HAVCR2, ZC3HAV1 | DGAT1 4414/4885MEN1 3004/4885KMT2A 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.